Euthymics Bioscience has added $4 million to its series A financing to fund preclinical development of its second product candidate, EB-1020, a non-stimulant for adult attention deficit hyperactivity disorder (ADHD). The product is "a.....
The clinical-stage European biotechnology company Creabilis says it hopes to complete Phase IIb studies of its topical TrkA kinase inhibitor, CT327, for psoriasis by the end of the third quarter of 2012, after reporting positive Phase IIa data. "Our.....
ARYx Therapeutics is winding down its operations after being informed by the US FDA that there will be a further delay in providing the much needed guidance on the Phase III development of the serotonin type 4 (5HT4) agonist, naronapride,.....
In a Paris court, Astellas lost its lawsuit against Prescrire, the influential drug bulletin for healthcare professionals in France, after the Japanese firm challenged Prescrire's review of its eczema treatment, Protopic.....
Pierre-Fabre is to appeal against the rejection by NICE, the health technology appraisal institute for England and Wales, of the firm's anticancer, Javlor (vinflunine), as a second-line treatment for bladder cancer. Martin Grange, .....
NICE, the health technology appraisal institute for England and Wales, has issued final draft guidance rejecting Roche's Tarceva (erlotinib) as a maintenance treatment for patients with non-small cell lung cancer. Roche confirmed to.....
The EU's Council of Ministers has given the go-ahead to a special procedure aimed at creating a single patent valid in all participating EU member states. The European Commission will now draft concrete proposals on the patent and the associated.....
Euthymics Bioscience has added $4 million to its series A financing to fund preclinical development of its second product candidate, EB-1020, a non-stimulant for adult attention deficit hyperactivity disorder (ADHD). The product is "a.....
The World Health Organization has formally confirmed that China's State FDA complies with international standards for the regulation of vaccines, a step that clears the way for Chinese producers to get their products prequalified by the.....
Dr Reddy's Laboratories is set for a significant scale-up of its operations in the US, including developing partnerships with other firms and a possible rebuilding of its research presence in this critical market.
